Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial - Girard, N; Mornex, F; Douillard, J (Lung Cancer, 2010)
et al.